Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-19-023185
Filing Date
2019-07-01
Accepted
2019-07-01 16:09:54
Documents
2
Period of Report
2019-06-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 6219
2 POWER OF ATTORNEY (PUBLIC): POA FRANCOIS doc1.txt EX-24 3952
  Complete submission text file 0001127602-19-023185.txt   11537
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address
Francois Cedric (Reporting) CIK: 0001658080 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38276 | Film No.: 19933300